Atlas Trials

Decitabine, Cytarabine, and Daunorubicin Hydrochloride in Treating Patients With Acute Myeloid Leukemia

Clinical trial NCT01627041 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT01627041
Sponsor
National Cancer Institute (NCI)
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Acute Myeloid LeukemiaAdult Acute Basophilic LeukemiaAdult Acute Monoblastic LeukemiaAdult Acute Monocytic LeukemiaAdult Acute Myeloid Leukemia With MaturationAdult Acute Myeloid Leukemia With t(9;11)(p21.3;q23.3); MLLT3-KMT2AAdult Acute Myeloid Leukemia Without MaturationAdult Acute Myelomonocytic LeukemiaAlkylating Agent-Related Acute Myeloid LeukemiaSecondary Acute Myeloid Leukemia
Start date
2011-09-16
Primary completion
2016-02-11
Enrollment
178

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.